UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

Neurology, 2020-09, Vol.95 (12), p.e1754

2020

Volltextzugriff (PDF)

HIV-1 replication in the central nervous system occurs in two distinct cell types

PLoS pathogens, 2011-10, Vol.7 (10), p.e1002286-e1002286

2011

Volltextzugriff (PDF)

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

BMC infectious diseases, 2011-12, Vol.11 (1), p.356-356, Article 356

2011

Volltextzugriff (PDF)

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients

PloS one, 2014-02, Vol.9 (2), p.e88591-e88591

2014

Volltextzugriff (PDF)

Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient

PLoS pathogens, 2013-05, Vol.9 (5), p.e1003347-e1003347

2013

Volltextzugriff (PDF)

Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection

PLoS pathogens, 2015-03, Vol.11 (3), p.e1004720-e1004720

2015

Volltextzugriff (PDF)

Large Differences in Small RNA Composition Between Human Biofluids

Cell reports (Cambridge), 2018-10, Vol.25 (5), p.1346-1358

2018

Volltextzugriff (PDF)

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

EBioMedicine, 2016-01, Vol.3 (C), p.135-140

2016

Volltextzugriff (PDF)

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

PloS one, 2019-12, Vol.14 (12), p.e0226276

2019

Volltextzugriff (PDF)

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

PloS one, 2016-06, Vol.11 (6), p.e0157160-e0157160

2016

Volltextzugriff (PDF)

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection

PloS one, 2014-12, Vol.9 (12), p.e116081-e116081

2014

Volltextzugriff (PDF)

Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection

The Journal of Infectious Diseases, 2008-05, Vol.197 (Supplement-3), p.S294-S306

2008

Volltextzugriff (PDF)

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance

PloS one, 2020-07, Vol.15 (7), p.e0236162-e0236162

2020

Volltextzugriff (PDF)

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression

PloS one, 2021-05, Vol.16 (5), p.e0250987-e0250987

2021

Volltextzugriff (PDF)

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

PLoS pathogens, 2009-04, Vol.5 (4), p.e1000395-e1000395

2009

Volltextzugriff (PDF)

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy

Current HIV/AIDS reports, 2015-06, Vol.12 (2), p.280-288

2015

Volltextzugriff (PDF)

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

AIDS research and therapy, 2010-06, Vol.7 (1), p.15-15

2010

Volltextzugriff (PDF)

Neuroimmunology of CNS HIV Infection: A Narrative Review

Frontiers in neurology, 2022-06, Vol.13, p.843801-843801

2022

Volltextzugriff (PDF)

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

BMC neurology, 2021-12, Vol.21 (1), p.494-494, Article 494

2021

Volltextzugriff (PDF)

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection

PloS one, 2009-09, Vol.4 (9), p.e6877-e6877

2009

Volltextzugriff (PDF)

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

BMC neurology, 2022-05, Vol.22 (1), p.197-197, Article 197

2022

Volltextzugriff (PDF)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

BMC neurology, 2009-12, Vol.9 (1), p.63-63, Article 63

2009

Volltextzugriff (PDF)

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series

Neurology, 2021-01, Vol.96 (2), p.e294

2021

Volltextzugriff (PDF)

1 – 25 von 1.056

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(943)
Mit Volltextzugriff
(866)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(671)
Life Sciences & Biomedicine
(507)
Humans
(433)
Female
(221)
Male
(201)
Adult
(142)
Middle Aged
(136)
Physical Sciences
(90)
Animals
(89)
Aged
(85)
Science & Technology - Other Topics
(82)
Neurosciences & Neurology
(80)
Hiv
(76)
Multidisciplinary Sciences
(76)
Neurosciences
(71)
Immunology
(70)
Infectious Diseases
(65)
Human Immunodeficiency Virus
(58)
General & Internal Medicine
(55)
Cerebrospinal Fluid
(52)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

HIV-1 replication in the central nervous system occurs in two distinct cell types

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients

Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient

Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

Large Differences in Small RNA Composition Between Human Biofluids

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection

Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

Neuroimmunology of CNS HIV Infection: A Narrative Review

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series

Aktive Filter

Suchergebnisse filtern